Psyence Biomedical Ltd.
PBMWW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001985062
No open-market purchases or sales by Psyence Biomedical Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $121.6K in total; no superinvestor holds it.
Other share classesPBM
13F holders, Q2 2026
Institutional positions in Psyence Biomedical Ltd. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- 0 vs. Q1 2026
- Shares held
- 5.19M
- −101.8K (−1.9%) vs. Q1 2026
- Total value
- $121.6K
- +$25.0K (+25.9%) vs. Q1 2026
- New holders
- 2
- 0 more added
- Sold out
- 2
- 4 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBMWW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $121.6K |
| Q1 2026 | 19 | $96.6K |
| Q4 2025 | 21 | $101.1K |
| Q3 2025 | 23 | $142.4K |
| Q2 2025 | 23 | $123.8K |
| Q1 2025 | 23 | $96.4K |
| Q4 2024 | 22 | $80.2K |
| Q3 2024 | 23 | $80.5K |
| Q2 2024 | 28 | $75.6K |
| Q1 2024 | 30 | $514.2K |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Psyence Biomedical Ltd.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Harraden Circle Investments, LLC | 1,149,000 | $27.9K | 0.00% | −1,000−0.1% | Reduced |
| Polar Asset Management Partners Inc. | 733,000 | $16.6K | 0.00% | 00.0% | Unchanged |
| MMCAP International Inc. SPC | 600,000 | $14.6K | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 503,012 | $12.1K | 0.00% | −300−0.1% | Reduced |
| Calamos Advisors LLC | 500,000 | $10.5K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 297,847 | $7.24K | 0.00% | 00.0% | Unchanged |
| Clear Street Group Inc. | 257,202 | $6.25K | 0.00% | −70.0% | Reduced |
| Goldman Sachs Group Inc | 200,117 | $4.86K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 200,000 | $4.86K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 175,352 | $3.68K | 0.00% | 00.0% | Unchanged |
| Tenor Capital Management Co., L.P. | 150,000 | $3.65K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 147,101 | $3.58K | 0.00% | 00.0% | Unchanged |
| Aristeia Capital LLC | 115,319 | $2.62K | 0.00% | −100,000−46.4% | Reduced |
| LPL Financial LLC | 49,095 | $1.19K | 0.00% | 00.0% | Unchanged |
| Mint Tower Capital Management B.V. | 50,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 27,500 | $668 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 10,119 | $212 | 0.00% | +10,119 | New |
| Ancora Advisors, LLC | 5,000 | $121 | 0.00% | 00.0% | Unchanged |
| SkyView Investment Advisors, LLC | 17,500 | $0 | 0.00% | +17,500 | New |
| Virtu Financial LLC | 0 | $0 | 0.00% | −27,853−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −247−100.0% | Sold out |